Built-in electric field construction in NH2-MIL-125/titanate nanotubes heterojunction for enhanced photocatalytic degradation of cephalexin in water
Chinese Chemical Letters · 2026-06 · 113124
DOI: 10.1016/j.cclet.2026.113124 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Chemical Letters, 2026-06. Verfasst von Yue Liu und 7 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Natural Science Foundation of Beijing Municipality, Beijing National Laboratory for Molecular Sciences, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Natural Science Foundation of Beijing Municipality
- Beijing National Laboratory for Molecular Sciences
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Major Science and Technology Projects in Yunnan Province
- Sichuan University of Science and Engineering
- Peking University
- National Key Research and Development Program of China
Zitieren
APA
Liu, Y., Yin, S., Xu, C., Liu, X., Qian, T., Chen, L., Sun, W., & Li, F. (2026). Built-in electric field construction in NH2-MIL-125/titanate nanotubes heterojunction for enhanced photocatalytic degradation of cephalexin in water. Chinese Chemical Letters, 113124. https://doi.org/10.1016/j.cclet.2026.113124
Vancouver
Liu Y, Yin S, Xu C, Liu X, Qian T, Chen L, et al. Built-in electric field construction in NH2-MIL-125/titanate nanotubes heterojunction for enhanced photocatalytic degradation of cephalexin in water. Chinese Chemical Letters. 2026:113124. doi:10.1016/j.cclet.2026.113124
BibTeX
@article{Liu2026,
author = {Liu, Yue and Yin, Shimei and Xu, Chaokai and Liu, Xiaona and Qian, Tianwei and Chen, Long and Sun, Weiliang and Li, Fan},
title = {Built-in electric field construction in NH2-MIL-125/titanate nanotubes heterojunction for enhanced photocatalytic degradation of cephalexin in water},
journal = {Chinese Chemical Letters},
year = {2026},
pages = {113124},
doi = {10.1016/j.cclet.2026.113124}
}
EUVIMED